Connect with us

Health

EU Ministers Back Biotech Rule Overhaul to Boost Innovation and Organ Transplant Cooperation

Published

on

EU health ministers have agreed on a common position to update biotechnology and organ transplantation rules, as the bloc seeks to strengthen its competitiveness in a sector increasingly dominated by the United States and China.

The agreement, reached on 16 June, forms part of the broader Biotech Act package and focuses on revisions to two existing directives covering genetically modified micro-organisms (GMMs) and organ processing procedures. The reforms aim to make regulatory frameworks more flexible, reduce administrative burdens, and improve cross-border cooperation in medical and scientific fields.

Officials say the changes are intended to help Europe catch up in biotechnology innovation, where global rivals have accelerated investment and development in recent years.

Cyprus Health Minister Neophytos Charalambides, who led the negotiations, said the update reflects scientific and technological advances that have taken place since the original rules were introduced. He described the revision as both a practical adjustment and an ethical necessity, given the pace of change in the sector.

Under the revised approach, EU countries agreed to adjust terminology in the European Commission’s proposal. The term “low-risk GMMs” has been replaced with “GMMs eligible for an expedited procedure”, reflecting a more streamlined approval pathway. In addition, consent for placing certain GMMs on the market may now be valid for up to ten years, instead of indefinitely.

The agreement also introduces provisions allowing personal data processing to be treated as serving the public interest in specific cases, particularly where it supports medical or scientific outcomes.

In the area of organ transplantation, member states agreed to extend the implementation period for updated rules from 24 months to 36 months, giving national health systems additional time to adapt to the new requirements.

See also  AI Tool Could Help Target Prostate Cancer Treatment, Improve Patient Outcomes

While the compromise was largely supported, discussions highlighted continuing tensions within the EU over how to balance innovation with safety oversight. Several member states stressed the importance of maintaining strict ethical safeguards, protecting personal data, and preserving national control over transplant systems.

The agreement among member states allows negotiations with the European Parliament to begin once it finalises its position. Lawmakers in the Parliament’s Health (SANT) and Environment (ENVI) committees are currently reviewing the proposal, with MEPs Adam Jarubas of the European People’s Party and Marta Temido of the Socialists and Democrats leading the process.

Charalambides also suggested that upcoming talks should take into account an opinion issued by the European Data Protection Supervisor in late May, noting that it arrived too late to be fully incorporated into the Council’s position.

As Cyprus concludes its presidency of the Council of the EU, responsibility for advancing the file now passes to Ireland, which will guide the next stage of negotiations between member states and the European Parliament.

Health

Wildfire Smoke Poses Growing Air Pollution Risk for Pregnant Women, Study Finds

Published

on

Wildfire smoke is becoming an increasing threat to pregnant women as climate change drives more frequent and intense fires, potentially undermining improvements made in air quality through reductions in pollution from transport and industry.

A new study published in Frontiers in Environmental Health examined exposure to fine particulate matter, known as PM2.5, from wildfires across the United States between 2003 and 2019. Researchers found that prenatal exposure to wildfire smoke more than doubled during the 17-year period.

The increase was particularly significant in western US states, where wildfire seasons have become longer and fires have grown more severe. Researchers found that wildfire smoke was responsible for about 65% of days when air pollution reached levels considered unsafe during pregnancy.

The findings suggest that progress in reducing pollution from human activities is being partly offset by emissions from wildfires.

“Increasing wildfire activity is systematically offsetting prenatal air quality gains,” researchers said, warning that the trend could place a disproportionate burden on low-income, rural and Indigenous communities as wildfire activity continues to intensify.

PM2.5 consists of microscopic particles that can travel deep into the lungs and enter the bloodstream. Exposure during pregnancy has previously been associated with health problems including premature birth and low birth weight.

Researchers also noted that particles produced by wildfires may pose additional risks because their chemical composition can differ from pollution produced by traffic and industrial activity. This could make wildfire smoke particularly concerning for people who are more vulnerable to air pollution.

The findings have implications beyond the United States, as Europe has also experienced increasingly severe wildfire seasons in recent years.

See also  Female Footballers Face More Severe Injuries During Menstruation, Study Finds

Countries including Greece, Portugal, Spain and France have faced major fires during successive summers, with smoke sometimes spreading across national borders. European climate and health authorities have warned that rising temperatures are contributing to conditions that increase the likelihood and intensity of wildfires.

The growing exposure has raised concerns about how public health systems can protect vulnerable groups as climate-related risks increase.

Experts say governments may need to strengthen guidance for pregnant women and other groups at higher risk from smoke exposure. Measures could include improved wildfire smoke forecasting, earlier health warnings and greater access to clean indoor air during periods of severe pollution.

The research highlights a challenge facing environmental policymakers. While decades of measures have reduced pollution from vehicles, industry and other human activities, climate change is creating additional sources of harmful air pollution.

Continue Reading

Health

Good Sleep May Matter More Than Diet or Exercise for Teenagers’ School Performance

Published

on

Good sleep may have a stronger influence on teenagers’ academic performance and social lives than diet, exercise or screen time, according to new research examining the daily factors that shape young people’s well-being.

The findings suggest that sleep could be particularly important for children experiencing symptoms of depression, anxiety or psychotic-like experiences, which have been linked to difficulties at school and in relationships.

Researchers examined data from more than 6,000 children for academic performance and more than 7,000 for social difficulties. The participants were aged between 10 and 13 and were assessed on four lifestyle factors: sleep quality, screen use, physical activity and diet.

Children showing symptoms of mental health difficulties generally performed worse academically and experienced more social problems. However, researchers found that lifestyle habits appeared to explain a significant part of this relationship, with sleep standing out as the most important factor.

“We expected sleep to be important, but we didn’t expect it to stand out so clearly above other lifestyle factors, particularly screen time,” said Jason Smucny, the study’s lead author at the University of California, Davis.

Researchers said poor sleep can cause daytime tiredness, problems with concentration and weaker executive functioning, all of which can make it harder for students to learn, complete schoolwork and perform well in examinations.

Sleep may also affect relationships. Disrupted or inadequate sleep can contribute to irritability and social withdrawal, potentially making it harder for young people to communicate with friends and maintain healthy relationships.

The researchers said their findings point to sleep quality as an important pathway through which early mental health symptoms can affect everyday functioning.

See also  French Senate Rejects Assisted Dying Bill, Sends It Back to Lower House

Tara Niendam, the study’s senior author, said parents, teachers and health professionals often concentrate on symptoms such as anxiety and depression, but families are also concerned about how those difficulties affect school performance, friendships and daily activities.

The research suggests that improving sleep routines could be one practical way of supporting young people facing these challenges.

Adolescents have increasingly struggled to get enough sleep, with previous research indicating that teenage sleep levels have declined over recent decades. School demands, social activities, technology use and changing schedules can all interfere with regular sleeping patterns.

The researchers stressed that better sleep cannot address every mental health problem. However, establishing consistent sleep routines may support emotional health and help young people manage the demands of school and social life.

With summer giving students an opportunity to recover from demanding school schedules, the findings highlight the potential importance of using the break to establish healthier and more consistent sleeping habits before the new academic year begins.

Continue Reading

Health

Study Suggests GLP-1 Weight-Loss Drugs May Lower Fracture Risk in People With Type 2 Diabetes

Published

on

A large US study has found that GLP-1 medicines, including widely prescribed treatments such as Ozempic, may reduce the risk of serious bone fractures in people with type 2 diabetes, challenging concerns that rapid weight loss associated with the drugs could weaken bones.

Researchers reported that patients treated with GLP-1 medicines had a 21% lower risk of fragility fractures over a three-year period compared with similar patients who received DPP-4 medicines, another class of drugs commonly used to manage type 2 diabetes.

The findings are based on an analysis of health records from more than 133,000 adults aged between 50 and 90 in the United States who were treated for type 2 diabetes between 2015 and 2022.

People living with type 2 diabetes face a greater risk of fractures caused by low-energy incidents, such as falls from standing height, even though they often have normal or higher-than-average bone density. Researchers said this may be linked to reduced bone strength, changes in bone structure and faster bone loss rather than bone density alone.

The study found the greatest reductions in vertebral fractures, which declined by 32%, while hip and femur fractures fell by 30% among patients taking GLP-1 medicines.

Researchers also noted that the lower fracture risk appeared to be independent of changes in body weight or blood sugar control. This raises the possibility that the medicines may have a direct effect on bone health rather than reducing fractures simply through weight loss or improved diabetes management.

The results challenge long-standing concerns that rapid weight loss could increase fracture risk by reducing bone density. Those concerns have accompanied the growing use of GLP-1 medicines, which have become increasingly popular for treating both type 2 diabetes and obesity.

See also  Female Footballers Face More Severe Injuries During Menstruation, Study Finds

Despite the encouraging findings, the researchers stressed that the study does not establish a direct cause-and-effect relationship. Because the research was based on observational health records rather than a randomized clinical trial, other factors may have influenced the results. Differences in physical activity, muscle strength, nutrition and existing bone health could all have contributed to the lower fracture rates.

The study also found no evidence that GLP-1 medicines reduced fracture risk among people who were taking the drugs without having type 2 diabetes. That suggests the apparent benefit may be specific to patients with diabetes and may not extend to those using the medicines solely for weight management.

The authors said additional prospective clinical trials are needed to confirm whether GLP-1 medicines provide direct protection against fractures and to determine whether any benefits continue during longer periods of treatment.

The findings add to growing research into the wider health effects of GLP-1 medicines as their use continues to expand around the world for diabetes care and weight management.

Continue Reading

Trending